Brevan Howard Capital Management LP

Position in INCY — Incyte Corp

CIK 1512857 ST. HELIER, Y9

Position in INCY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,371,685

+$3,925,640 QoQ

Shares Held

46,448

+928.5% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Brevan Howard Capital Management LP holds $135,070,881 across 172 Biotechnology names. INCY ranks #8 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	81,570	$6,057,388
2	ASND	Ascendis Pharma A/S	26,200	$5,992,726
3	SNDX	Syndax Pharmaceuticals Inc	204,845	$4,785,179
4	TERN	Terns Pharmaceuticals, Inc.	88,596	$4,670,780
5	MRNA	Moderna, Inc.	89,594	$4,551,375
6	SLNO	Soleno Therapeutics Inc	135,621	$4,540,590
7	RARE	Ultragenyx Pharmaceutical Inc.	215,845	$4,521,951
8	INCY	Incyte Corp This page	46,448	$4,371,685

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,371,685	46,448	+928.5%	Shares	Defined	2026-05-15
2025-12-31	$446,045	4,516	+27.7%	Shares	Defined	2026-02-17
2025-09-30	$299,888	3,536	-77.1%	Shares	Defined	2025-11-14
2025-03-31	$933,801	15,422	-70.9%	Shares	Defined	2025-05-15
2024-12-31	$3,657,463	52,953	+43.9%	Shares	Defined	2025-02-14
2024-09-30	$2,431,752	36,789	+61.9%	Shares	Defined	2024-11-14
2024-06-30	$1,377,468	22,723	+66.7%	Shares	Defined	2024-08-14
2024-03-31	$776,615	13,632	+114.1%	Shares	Defined	2024-05-15
2023-12-31	$399,783	6,367	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.